Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'The Future of Personalized Medicine' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Cancer Personalized Medicine 2008 |
July 2008 | £2425 | 35 % |
|
Commercial Opportunities from Biomarkers Transforming drug discovery, clinical development and molecular diagnostic |
May 2006 | £1495 | 27 % |
|
Molecular Diagnostics Technologies, Markets and Companies |
March 2010 | £3300 | 26 % |
|
Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis 3rd Edition |
November 2008 | £2640 | 25 % |
|
Next-Generation Nutraceuticals Food and pharma convergence in disease prevention and personalized nutrition |
December 2006 | £1495 | 24.5 % |
|
Impact of Pharmacogenomics on Public Healthcare Policy Educating Patients, Payors and Healthcare Providers |
March 2008 | £1995 | 24 % |
|
Innovations in Diagnostics |
September 2006 | £1495 | 23.8 % |
|
Global Molecular Diagnostics Market Opportunities & Future Forecast |
August 2009 | £660 | 23.1 % |
|
The Future of Biobanks Regulation, ethics, investment and the humanization of drug discovery |
March 2009 | £2025 | 21.5 % |
|
Biomarkers: The Future of Next-Generation Drug R&D |
September 2008 | £1715 | 21.35 % |
|
Biomarkers, Tests and Trends for Drug R&D |
February 2010 | £1450 | 20.65 % |
|
The Epigenetics Healthcare R&D, Products and Commercial Implications Tools, Technologies, Equipment, Opportunities & Emerging WW Market Outlook |
January 2009 | £1515 | 19.5 % |
|
Companion Diagnostics in Personalized Medicine and Cancer Therapy |
April 2008 | £2245 | 18.9 % |
|
Cytogenetics Technologies, Markets and Companies |
March 2010 | £1455 | 16.1 % |
|
Molecular Diagnostics 2007 Technologies, Companies, Products, Applications and Worldwide Outlook |
May 2007 | £1515 | 15.05 % |
|
Commercializing Molecular Diagnostics: Products, Services, Companies and Global Market |
July 2008 | £1715 | 14.7 % |
|
Personalized Medicine Scientific & Commercial Aspects |
March 2010 | £2640 | 13.65 % |
|
Multiplex Assays in Translational Medicine Technologies, Applications, and Future Directions |
February 2008 | £745 | 12.95 % |
|
U.S.DNA-Based Diagnostic and Test Market |
January 2008 | £1850 | 12.95 % |
|
Stakeholder Opinions: Diagnostics in Neurology Predictive Biomarkers Expand Drug Revenues |
July 2008 | £1320 | 12.6 % |
|
DNA Sequencing Technologies, Markets and Companies |
March 2010 | £1190 | 12.6 % |
|
Bioinformatics Technical Status and Market Prospects |
August 2005 | £2885 | 10.15 % |
|
Cell-Based Diagnostics: Technology, Applications, and Markets 2nd Edition |
November 2007 | £2640 | 9.8 % |
|
From blockbuster to nichebuster Niche therapies drive future drugs growth and incentivize R&D investment over sales spending |
July 2006 | £695 | 8.75 % |
|
Cardiac Marker Diagnostic Testing Markets |
May 2008 | £2245 | 8.4 % |
|
Antiviral Therapeutics Technologies, Markets and Companies |
March 2010 | £2115 | 8.4 % |
|
DNA Sequencing and PCR Markets |
July 2008 | £2245 | 8.4 % |
|
Outlook for RNAi, 2007 siRNA and miRNA in biology, diagnostics and therapeutics |
June 2007 | £1495 | 8.4 % |
|
Respiratory Measurement Devices Clinical Trial Analysis |
July 2009 | £660 | 8.05 % |
|
Proteomics Technologies, Markets and Companies |
March 2010 | £2970 | 8.05 % |
|
Direct-To-Consumer Genetic Testing Business Prospects in the United States |
March 2009 | £2475 | 7.7 % |
|
Biomarkers Technologies, Markets and Companies |
March 2010 | £2970 | 7.7 % |
|
Molecular Diagnostics Markets |
September 2008 | £2245 | 7.35 % |
|
Cancer Biomarkers Enhancing diagnostic, therapeutic and developmental strategies |
May 2006 | £1450 | 7 % |
|
RNAi Technologies, Markets and Companies |
March 2010 | £2310 | 7 % |
|
Biomarkers The Expanding Global Market |
November 2007 | £3205 | 6.65 % |
|
Epigenomics Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics |
March 2007 | £3205 | 6.65 % |
|
The Worldwide Market for In Vitro Diagnostic Tests 6th Edition [with 2009 Economy Preface] |
May 2008 | £2640 | 5.6 % |
|
Companion Biomarkers in Drug Development |
April 2009 | £2245 | 5.6 % |
|
Molecular Diagnostics in Cancer Testing |
December 2009 | £2245 | 5.25 % |
|
Nanobiotechnology Applications, Markets and Companies |
March 2010 | £2970 | 4.9 % |
|
Pain Therapeutics Drugs, Markets and Companies |
March 2010 | £2310 | 4.9 % |
|
Cell Therapy Technologies, Markets and Companies |
March 2010 | £3300 | 4.2 % |
|
Medical Device Development Regulation and Law |
September 2009 | £160 | 4.2 % |
